{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:48:40Z","timestamp":1778798920591,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.dld.2025.02.008","type":"journal-article","created":{"date-parts":[[2025,3,23]],"date-time":"2025-03-23T06:39:54Z","timestamp":1742711994000},"page":"1301-1307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical characteristics and risk factors of hepatocellular carcinoma development in Budd-Chiari syndrome patients after endovascular treatment"],"prefix":"10.1016","volume":"57","author":[{"given":"Qianxin","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maoheng","family":"Zu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuming","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caifang","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2025.02.008_bib0001","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMra2207738","article-title":"Primary Budd-Chiari Syndrome","volume":"388","author":"Garcia-Pag\u00e1n","year":"2023","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.dld.2025.02.008_bib0002","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1111\/liv.14131","article-title":"Budd-Chiari syndrome in the West and the East: same syndrome, different diseases","volume":"39","author":"Mancuso","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2025.02.008_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-8278(95)80252-5","article-title":"Epidemiological and clinical features of Budd-Chiari syndrome in Japan","volume":"22","author":"Okuda","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2025.02.008_bib0004","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/liv.13008","article-title":"Incidence, prevalence and complications of Budd-Chiari syndrome in South Korea: a nationwide, population-based study","volume":"36","author":"Ki","year":"2016","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.dld.2025.02.008_bib0005","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.dld.2018.04.004","article-title":"The epidemiology of Budd-Chiari syndrome in France","volume":"50","author":"Ollivier-Hourmand","year":"2018","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2025.02.008_bib0006","doi-asserted-by":"crossref","first-page":"118","DOI":"10.21037\/hbsn-22-584","article-title":"Tailoring stepwise treatment for Budd-Chiari syndrome: insights from the Asian Pacific Association for the Study of the Liver (APASL) consensus guidance","volume":"12","author":"Haque","year":"2023","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.dld.2025.02.008_bib0007","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12072-021-10189-4","article-title":"Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)","volume":"15","author":"Shukla","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.dld.2025.02.008_bib0008","article-title":"Budd-Chiari syndrome and its associated hepatocellular carcinoma: clinical risk factors and potential immunotherapeutic benefit analysis","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.dld.2025.02.008_bib0009","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/gut.2007.139477","article-title":"Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors","volume":"57","author":"Moucari","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.dld.2025.02.008_bib0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/liv.13219","article-title":"Characteristics of hepatocellular carcinoma in Egyptian patients with primary Budd-Chiari syndrome","volume":"37","author":"Sakr","year":"2017","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.dld.2025.02.008_bib0011","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/1751-2980.13294","article-title":"Chinese Medical Association. Chinese consensus on the management of liver cirrhosis","volume":"25","year":"2024","journal-title":"J Dig Dis"},{"key":"10.1016\/j.dld.2025.02.008_bib0012","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00270-014-0980-4","article-title":"Efficacy and safety of endovascular intervention for the management of primary entire-inferior vena cava occlusion","volume":"38","author":"Zhang","year":"2015","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.dld.2025.02.008_bib0013","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.003104","article-title":"Comparison of long-term outcomes of endovascular management for membranous and segmental inferior Vena Cava obstruction in patients with primary Budd-Chiari Syndrome","volume":"9","author":"Huang","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.dld.2025.02.008_bib0014","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ejvs.2014.01.014","article-title":"Strategy and long-term outcomes of endovascular treatment for Budd-Chiari syndrome complicated by inferior vena caval thrombosis","volume":"47","author":"Zhang","year":"2014","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.dld.2025.02.008_bib0015","first-page":"972","article-title":"Analysis of curative efficacy of transjugular intrahepatic portosystemic shunt using viabahn stent in the treatment of Budd-Chiari syndrome with extensive hepatic vein occlusion","volume":"29","author":"Zhao","year":"2021","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"1","key":"10.1016\/j.dld.2025.02.008_bib0016","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2025.02.008_bib0017","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00042737-200403000-00012","article-title":"Characteristic clinical features of hepatocellular carcinoma associated with Budd-Chiari syndrome: evidence of different carcinogenic process from hepatitis B virus-associated hepatocellular carcinoma","volume":"16","author":"Shin","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.02.008_bib0018","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3748\/wjg.v18.i16.1946","article-title":"Hepatocellular carcinoma in Budd-Chiari syndrome: a single center experience with long-term follow-up in South Korea","volume":"18","author":"Park","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2025.02.008_bib0019","first-page":"9071","article-title":"Studies on Budd-chiari syndrome complicated with hepatocellular carcinoma: most patients without inferior vena cava obstruction","volume":"8","author":"Dang","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"10.1016\/j.dld.2025.02.008_bib0020","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4251\/wjgo.v16.i3.699","article-title":"Clinical profile and outcomes of hepatocellular carcinoma in primary Budd-Chiari syndrome","volume":"16","author":"Agarwal","year":"2024","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.dld.2025.02.008_bib0021","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1148\/radiol.09090738","article-title":"Hepatocellular carcinoma associated with membranous obstruction of the inferior vena cava: incidence, characteristics, and risk factors and clinical efficacy of TACE","volume":"254","author":"Gwon","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.dld.2025.02.008_bib0022","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.3760\/cma.j.issn.0366-6999.20130898","article-title":"Clinical and pathological features and surgical treatment of Budd-Chiari syndrome-associated hepatocellular carcinoma","volume":"126","author":"Wang","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.dld.2025.02.008_bib0023","unstructured":"Xu Z.Q., Wang Y.D., Zhang X., et al. Zhonghua Yi Xue Za Zhi. 2019;99(16):1241\u20135."},{"issue":"1","key":"10.1016\/j.dld.2025.02.008_bib0024","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3390\/metabo13010035","article-title":"Genetic predisposition to hepatocellular carcinoma","volume":"13","author":"Pascale","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.dld.2025.02.008_bib0025","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.cgh.2022.08.042","article-title":"Minimal risk of hepatocellular carcinoma in noncirrhotic Budd-Chiari syndrome: a three-decade population-based study","volume":"21","author":"Wester","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.02.008_bib0026","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1007\/s00261-021-02977-1","article-title":"Recanalization of accessory hepatic vein for hepatic vein-type Budd-Chiari syndrome","volume":"46","author":"Lv","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.dld.2025.02.008_bib0027","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/MEG.0000000000001784","article-title":"Long-term outcomes of interventional treatment for Budd-Chiari syndrome with chronic accessory hepatic vein obstruction","volume":"33","author":"Li","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.02.008_bib0028","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/apt.13173","article-title":"Incidence and risk factors of hepatocellular carcinoma in patients with hepatic venous outflow tract obstruction","volume":"41","author":"Paul","year":"2015","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865825002440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865825002440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T15:23:53Z","timestamp":1748877833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865825002440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1590865825002440"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2025.02.008","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and risk factors of hepatocellular carcinoma development in Budd-Chiari syndrome patients after endovascular treatment","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2025.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}